Breadcrumbs Navigation

Home > News & Publications > News and Communications > News

Latest Health News from Duke Medicine News and Communications

 « Previous 10 Page of 30 Next 10 »

Newly Discovered Protein Has Link to Gestational Diabetes

For at least 40 years, scientists who study how the body metabolizes sugar have accepted one point: there are four enzymes that kick-start the body’s process of getting energy from food.

Duke’s Robert Califf Named as Deputy FDA Commissioner

Robert Califf, M.D., vice chancellor of clinical and translational research at Duke University School of Medicine and a global leader in cardiovascular medicine, clinical and translational research and medical economics, has been named deputy commissioner for Medical Products and Tobacco at the Food and Drug Administration.

High Cholesterol In 30s, 40s, Increases Later Risk Of Heart Disease

Most young adults might assume they have years before needing to worry about their cholesterol.

Human Mode Of Responding To HIV Vaccine Is Conserved From Monkeys

The antibody response from an HIV vaccine trial in Thailand was made possible by a genetic trait carried over in humans from an ancient ancestry with monkeys and apes, according to a study led by Duke Medicine researchers.

DCRI Awarded Federal Contract to Test New Anti-Infection Drugs

The Duke Clinical Research Institute will become one of three national sites to run early clinical trials of new anti-infection therapies under a contract announced by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

A. Eugene Washington, M.D., to Become Duke's Next Chancellor for Health Affairs

A. Eugene Washington, M.D., an internationally renowned clinical investigator, health-policy scholar and executive at the University of California, Los Angeles (UCLA), will become Duke University’s next chancellor for health affairs and the president and chief executive officer of the Duke University Health System, Duke President Richard H. Brodhead announced Tuesday.

Duke University Health System Temporarily Restricts Hospital Visitations

Researchers Map Paths to Cancer Drug Resistance

A team of researchers led by Duke Cancer Institute has identified key events that prompt certain cancer cells to develop resistance to otherwise lethal therapies.

‘Financial Toxicity’ Can Lower Cancer Patients' Quality of Life

Doctors who treat cancer are vigilant when it comes to the physical side effects of the therapies they prescribe, but financial stress from accumulating medical bills can also weigh on patients’ health — even those who have finished their treatments and are cancer-free.

Coffman Named Dean-designate, Duke-NUS Graduate Medical School Singapore

Dr. Thomas Coffman, M.D., has been named the dean-designate at the Duke-National University of Singapore Graduate Medical School (Duke-NUS).

 « Previous 10 Page of 30 Next 10 »